The School of Engineering and Applied Sciences welcomes 20 new faculty members this semester, who are renowned for their research and educational expertise.
Yahoo!Finance covered UB research co-authored by Jonathan Lovell, SUNY Empire Innovation Professor of biomedical engineering, suggesting a new COVID-19 vaccine candidate is amendable to multiple boosting regimes in the future.
The Institute of International Education ranked UB No. 25 in its latest census, “The Open Doors 2022 Report on International Educational Exchange. UB ranked No. 27 on the list the previous two years.
Eleven faculty members from the School of Engineering and Applied Sciences were among those recognized at the University at Buffalo’s Celebration of Faculty and Staff Academic Excellence.
Newswire and other websites report that UB spinoff POP Biotechnologies announced the start of two phase 3 clinical studies of EuCorVac-19, a COVID-19 vaccine candidate the startup is developing with South Korean partner EuBiologics.
The UB team that a decade ago helped usher in a new era in acute stroke treatment has turned its innovative approach to addressing the rare but potentially deadly phenomena when multiple blood clots strike deep in the veins of the brain.
